Skip to content

Clinical trials

Phase 4 Pleural Effusion, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 4 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20091
20101
20161
20181
20201
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University2
Grupo de Pesquisa em Pleura e Oncologia Toracica1
M.D. Anderson Cancer Center1
Mohamed Reda Ashour1
Mohamed Sabry1
Novartis Pharmaceuticals1
University of Sao Paulo1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant9
Pleural Effusion2
Bronchiolitis Obliterans Syndrome1
Carcinoma, Non-Small-Cell Lung1
Empyema, Pleural1
Hemothorax1
Lung Diseases1
Lung Neoplasms1
Mesothelioma, Malignant1
Pericardial Effusion1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.